Cite
HARVARD Citation
Laza‐Briviesca, R. et al. (2021). Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial. Clinical and translational medicine. 11 (7), p. n/a. [Online].